Showing results (911-920 of 1,215) with videos related to
Sort By:
Pageof 122
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 16, 2025
CF airway epithelia display exaggerated host defense responses and prolonged cilia loss during RSV infectionJennifer A Bartlett, Eric D Huntemann, Sateesh Krishnamurthy, et al.The Journal of Pain|March 13, 2024
Minimal Clinically Important Change of Movement Pain in Musculoskeletal Pain ConditionsTimothy R Fleagle, Andrew A Post, Dana L Dailey, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|August 13, 2016
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasisM Augustin, C Blome, C Paul, et al.Current Neuropharmacology|June 26, 2023
Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two CasesChiara Cambieri, Marco Marenco, Tania Colasanti, et al.Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Test-Retest Reliability and Responsiveness of PROMIS Sleep Short Forms Within an RCT in Women With FibromyalgiaRuth L Chimenti, Barbara A Rakel, Dana L Dailey, et al.Cardiovascular Drugs and Therapy|October 24, 2001
CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overloadS Masson, S Chimenti, M Salio, et al.Stem Cells Translational Medicine|March 16, 2017
Human Lung Spheroids as In Vitro Niches of Lung Progenitor Cells with Distinctive Paracrine and Plasticity PropertiesIsotta Chimenti, Francesca Pagano, Francesco Angelini, et al.Scientific Reports|November 15, 2016
Β-blockers treatment of cardiac surgery patients enhances isolation and improves phenotype of cardiosphere-derived cellsIsotta Chimenti, Francesca Pagano, Elena Cavarretta, et al.International Journal of Immunopathology and Pharmacology|April 30, 2014
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseasesC Blandizzi, P Gionchetti, A Armuzzi, et al.The British Journal of Dermatology|October 15, 2013
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)C Paul, L Puig, K Kragballe, et al.Pageof 122